Enanta Pharmaceuticals Inc (NASDAQ: ENTA) stock closed at $9.97 on 11/21/23 after a major increase of 11.5%. Relative to the market the stock has been extremely weak over the last nine months but has risen 21.9% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be in line with the cost of capital, ENTA is expected to continue to be Value Creation neutral.
Enanta Pharmaceuticals has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects inconsistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Enanta Pharmaceuticals has a neutral Appreciation Score of 45 but a very low Power Rating of 3, triggering the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment